The questions answered in this podcast are listed below.
They were compiled by GPs and professional attendees at our face-to-face seminars around Australia.

1. Is there a specific age at which women should be advised to stop MHT?
2. Can we restart MHT in a woman now in her early 60s who stopped MHT 3–4 years ago and has recurrent vasomotor symptoms?
3. Can MHT be initiated more than 10 years after menopause?
4. For women who missed the MHT window and are now in their late 60s or 70s, what are the options?
5. How do we manage symptomatic women over 60 requesting MHT for symptoms other than vasomotor symptoms, such as fatigue, muscle aches, or concerns about dementia and cardiovascular protection?
6. Can oral progesterone alone be used in women who missed the MHT window?
7. Can vaginal progesterone be used in women intolerant of oral progesterone?
8. Should women always have a pelvic ultrasound before initiating MHT?
9. How should bleeding on MHT be investigated and managed?
10. Is a baseline mammogram required before commencing MHT?
11. If MHT was started during perimenopause, when should it be changed to continuous combined therapy?
12. What is the impact of MHT on weight gain?
13. Is MHT safe in women with BRCA mutations?
14. What is the evidence for MHT use after breast cancer?
15. Is MHT safe in ovarian cancer survivors?
16. If MHT may be cardioprotective, why is it not recommended for primary prevention of cardiovascular disease?
17. Can women with a history of thrombosis use MHT?
18. Can topical Estrogel be used in a patient with Factor V Leiden?
19. Why do some menopause clinics prescribe progesterone after hysterectomy in women with a history of endometriosis?
20. Is Mirena sufficient endometrial protection with higher doses of Estrogel?
21. Is Slinda adequate for endometrial protection during MHT?

Expert: Prof Rod Baber AM, Obstetrician and Gynaecologist

Host: Dr Terri Foran, GP & Sexual Health Physician

Total time: 33 mins

Recommended resources

• Australasian Menopause Society